Skip to main content
. 2018 Nov;16(6):498–506. doi: 10.1370/afm.2312

Table 3.

Clinician Performance in 4 As Delivery and Patient Outcomes at Postintervention Assessment by Intervention Group

Parameter OMSC OMSC+

Pre
n = 540
Post
n = 394
AOR (95% CI)a P
Valueb
Pre
n = 583
Post
n = 473
AOR (95% CI)a P
Valueb
4 As delivery
Ask 47.3 55.9 1.45 (1.10-1.92) .009 46.8 65.7 2.40 (1.83-3.14)c <.001
Advise 38.1 48.1 1.63 (1.20-2.11) .001 42.5 53.5 1.71 (1.31-2.24) <.001
Assist 35.1 42.8 1.44 (1.09-1.91) .011 33.3 53.9 2.62 (1.99-3.45) <.001
 Set quit date 12.4 12.1 1.03 (0.68-1.55) .898 11.2 18.7 1.93 (1.33-2.79) .001
 Self-help 10.0 11.1 1.19 (0.77-1.84) .444 10.8 19.4 2.05 (1.42-2.98) .001
 Discuss medications 25.5 26.9 1.11 (0.81-1.51) .517 26.1 37.1 1.87 (1.41-2.50) <.001
 Prescribe medications 8.7 8.8 1.11 (0.68-1.80) .670 9.1 12.2 1.47 (0.96-2.27) .080
Arrange 12.2 13.4 1.10 (0.73-1.66) .649 10.3 22.5 2.66 (1.84-3.84) <.001
 Patient-level outcomes
 Quit attempts 29.0 30.0 1.01 (0.75-1.36)c .934 27.8 35.0 1.41 (1.07-1.86)c .015
 7-day point-prevalence abstinence (self-reported) 4.6 9.1 2.18 (1.25-3.82)c .006 6.0 6.5 1.13 (0.65-1.96) .669
 7-day point-prevalence abstinence (biochemically validated) 0.0 2.8 0.3 2.5 13.03 (1.65-102.84)c .015
 6-month continuous abstinence 4.1 6.6 1.75 (0.92-3.30) .086 4.0 4.8 1.30 (0.69-2.45) .423

AOR = adjusted odds ratio; OMSC = Ottawa Model for Smoking Cessation; post = postassessment; pre = preassessment.

a

Controlling for clinic-level variance between clusters, patient sex, patient education, and self-reported anxiety or depression; based on inclusion of 15 clinics unless otherwise indicated.

b

P value based on Wald statistic.

c

The estimated G matrix for clinic-level variance was not a definite positive, so clinic-level variance was not included in this model.